source
- Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckleyEli Lilly said on Thursday it will buy psychedelic drug developer AtaiBeckley for $2.8 billion upfront, in a move that further spotlights big pharma’s increasing interest in the space after years o…Endpoints · 14d ago↗ source
- STAT+: Spring forward forever? Another daylight saving debate arrives in CongressTrump's pandemic preparedness nominee testifies, the "fang-to-pharmacy" pipeline, and more health news from Morning RoundsSTAT · 14d ago↗ source
- Updated: Merck beats AstraZeneca to approval for first PCSK9 pillAs in football, so in pharmaceuticals: The English have been beaten. Merck has outpaced AstraZeneca in the race to get the first US approval for an oral form of a particular kind of cholesterol-low…